157 related articles for article (PubMed ID: 1971273)
1. Structural and functional characterization of the CD2 immunoadhesion domain. Evidence for inclusion of CD2 in an alpha-beta protein folding class.
Recny MA; Neidhardt EA; Sayre PH; Ciardelli TL; Reinherz EL
J Biol Chem; 1990 May; 265(15):8542-9. PubMed ID: 1971273
[TBL] [Abstract][Full Text] [Related]
2. Structural and binding analysis of a two domain extracellular CD2 molecule.
Sayre PH; Hussey RE; Chang HC; Ciardelli TL; Reinherz EL
J Exp Med; 1989 Mar; 169(3):995-1009. PubMed ID: 2466941
[TBL] [Abstract][Full Text] [Related]
3. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
Koyasu S; Lawton T; Novick D; Recny MA; Siliciano RF; Wallner BP; Reinherz EL
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2603-7. PubMed ID: 1690889
[TBL] [Abstract][Full Text] [Related]
4. The structural biology of CD2.
Moingeon P; Chang HC; Sayre PH; Clayton LK; Alcover A; Gardner P; Reinherz EL
Immunol Rev; 1989 Oct; 111():111-44. PubMed ID: 2576417
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of T cell activation and adhesion functions by soluble CD2 protein.
Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA
Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation is required for human CD2 immunoadhesion functions.
Recny MA; Luther MA; Knoppers MH; Neidhardt EA; Khandekar SS; Concino MF; Schimke PA; Francis MA; Moebius U; Reinhold BB
J Biol Chem; 1992 Nov; 267(31):22428-34. PubMed ID: 1385399
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
Somoza C; Driscoll PC; Cyster JG; Williams AF
J Exp Med; 1993 Aug; 178(2):549-58. PubMed ID: 7688025
[TBL] [Abstract][Full Text] [Related]
8. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the CD2 T lymphocyte antigen by site-directed mutagenesis to introduce a disulphide bond into domain 1.
Gray F; Cyster JG; Willis AC; Barclay AN; Williams AF
Protein Eng; 1993 Nov; 6(8):965-70. PubMed ID: 7508627
[TBL] [Abstract][Full Text] [Related]
10. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
11. [TRBC receptor on T lymphocytes of human and macaque and its ligand are different from E2 molecule and ligands for CD2].
Zheng YT; Ben KL
Shi Yan Sheng Wu Xue Bao; 1990 Sep; 23(3):357-62. PubMed ID: 1708938
[TBL] [Abstract][Full Text] [Related]
12. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.
van der Merwe PA; McNamee PN; Davies EA; Barclay AN; Davis SJ
Curr Biol; 1995 Jan; 5(1):74-84. PubMed ID: 7697352
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory properties of soluble recombinant human CD58 (LFA-3) molecules.
Albert-Wolf M; Meuer SC; Wallich R
Dev Biol Stand; 1992; 77():87-92. PubMed ID: 1385237
[TBL] [Abstract][Full Text] [Related]
14. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2.
Withka JM; Wyss DF; Wagner G; Arulanandam AR; Reinherz EL; Recny MA
Structure; 1993 Sep; 1(1):69-81. PubMed ID: 7915183
[TBL] [Abstract][Full Text] [Related]
15. Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen.
Beyers AD; Barclay AN; Law DA; He Q; Williams AF
Immunol Rev; 1989 Oct; 111():59-77. PubMed ID: 2576418
[TBL] [Abstract][Full Text] [Related]
16. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
17. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
18. Association of CD2 and CD45 on human T lymphocytes.
Schraven B; Samstag Y; Altevogt P; Meuer SC
Nature; 1990 May; 345(6270):71-4. PubMed ID: 1970422
[TBL] [Abstract][Full Text] [Related]
19. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
20. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway.
Albert-Wolf M; Meuer SC; Wallich R
Int Immunol; 1991 Dec; 3(12):1335-47. PubMed ID: 1723296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
